Democratizing hedge fund level analysis tools for everyone
Name | Prodia Widyahusada Tbk. |
Sector | Healthcare |
Industry | Healthcare Equipment & Providers |
Code | F1 |
Latest Quarterly | 06-30-25 |
Name | Latest % | A Month Ago % |
---|---|---|
PT. Prodia Utama | 57.0 | 57.0 |
Public < 5% | 24.8 | 24.8 |
Bio Majesty Pte. Ltd. | 15.0 | 15.0 |
Treasury Shares | 3.2 | 3.2 |
Others | 0.0 | 0.0 |
Ida Zuraida | 0.0 | 0.0 |
Source | 2022 | 2021 |
---|---|---|
Laboratory | 0.0% | 88.9% |
Clinic | 0.0% | 0.4% |
Routine | 70.1% | 0.0% |
Esoteric | 21.3% | 0.0% |
Non-Laboratory | 8.6% | 10.7% |
Others | 0.0% | 0.0% |
Region | 2022 | 2021 |
---|---|---|
Indonesia | 100.0% | 100.0% |
Others | 0.0% | 0.0% |
Valuation | Ratio | Rank |
---|---|---|
P/S | 1.27 | # 6 / 22 |
EV_EBITDA | 6.15 | # 2 / 22 |
PER | 18.78 | # 4 / 22 |
PBV | 1.12 | # 6 / 22 |
DER | 0.11 | # 1 / 22 |
Profitability | Ratio | Rank |
---|---|---|
NPM % | 6.8 | # 9 / 22 |
ROA % | 5.4 | # 7 / 22 |
ROE % | 5.9 | # 10 / 22 |
Year | DPS | Yield [%] |
---|---|---|
2025 | 172.9 | 0.0 |
2024 | 166.0 | 6.1 |
2023 | 237.8 | 4.4 |
2022 | 397.8 | 7.1 |
2021 | 172.0 | 1.9 |
Timeframe | Performance |
---|---|
1W % | 0.4 |
1Mo % | -3.1 |
3Mo % | 10.3 |
1Yr % | -7.6 |
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
PRDA | 18.78 | 2.74 T | 2.40 T | 2.05 T | 371 B | 139 B |
SRAJ | -674.89 | 58.75 T | 62.73 T | 3,202 B | 469 B | -114 B |
MIKA | 25.53 | 33.80 T | 33.13 T | 5,127 B | 1,945 B | 1,279 B |
SILO | 28.41 | 27.05 T | 30.51 T | 12,148 B | 2,616 B | 984 B |
HEAL | 57.53 | 23.59 T | 27.08 T | 6,777 B | 1,799 B | 450 B |
PRAY | 50.90 | 8.59 T | 10.01 T | 2,201 B | 464 B | 170 B |